--BP Physiological Monitors

This is a notice of intent, not a request for a proposal. A solicitation document will not be issued and proposals will not be requested. The National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP) intends to solicit, negotiate and award a purchase order on a noncompetitive basis with BIOPAC Systems, Inc., 42 Aero Camino, Goleta, CA 93117. National Institutes on Drug Abuse (NIDA), Division of Intramural Research in Baltimore, Maryland requires Noninvasive BP Monitor (NIBP100D). The appropriate statutory authority is 41 USC 253 (c) (1), as set forth in FAR 6.302-1(b)(1)(i). The cited authority is applicable because BIOPAC Systems, Inc. is the only source that can fulfill the requirements of this contract. An award to any other source would result in substantial duplication of cost to the Government that is not expected to be recovered through competition. The acquisition is being conducted under simplified acquisition FAR 13 and is exempt from the requirements of FAR Part 6, Competition Requirement. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this synopsis. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely with the discretion of the Government. Comments to this announcement, referencing synopsis number NIHDA2010167 may be submitted no later than 4:30 p.m. Eastern Standard Time on July 7, 2010 to NIDA/IRP, Biomedical Research Center, Suite 200, 251 Bayview Boulevard, Room 4A326, Baltimore, MD 21224, ATTN: Carol Lindsay